Kim T Brixen
Overview
Explore the profile of Kim T Brixen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nielsen D, Langdahl B, Sorensen O, Sorensen H, Brixen K
Scand J Public Health
. 2010 May;
38(5):502-7.
PMID: 20484306
Purpose: This study was undertaken to assess persistence with bisphosphonates and raloxifene and to identify determinants of adherence (patient age, level of information, educational status, etc.) among women with osteoporosis...
2.
Nielsen J, Jeppesen N, Brixen K, Horder K, Stoving R
Ugeskr Laeger
. 2008 Apr;
170(14):1158.
PMID: 18405483
The Centre for Eating Disorders at Odense University Hospital receives about 140 patients yearly. We reviewed the five lethal cases that occurred during the last 10 years. None of the...
3.
Nielsen T, Brixen K, Jespersen B
Ugeskr Laeger
. 2008 Feb;
170(4):244-7.
PMID: 18282456
Introduction: Tertiary hyperparathyroidism (3 degrees HPT) is a condition characterized by autonomous secretion of parathyroid hormone (PTH) which develops as a consequence of secondary hyperparathyroidism in patients with chronic renal...
4.
Folkestad L, Bjerregaard J, Bjarnason N, Brixen K
Ugeskr Laeger
. 2007 Jun;
169(19):1774-9.
PMID: 17537350
Aromatase inhibitors (AI) increase the disease-free survival of patients with receptor-positive breast cancer. They inhibit the endogenous production of estrogen by 50-90% and, in contrast to tamoxifen, reduce bone mineral...
5.
Frederiksen L, Junker P, Brixen K
Ugeskr Laeger
. 2007 May;
169(17):1583-4.
PMID: 17484832
A 62-year-old, previously healthy woman diagnosed with post-menopausal osteoporosis received alendronate 70 mg/week. One week after the first dose, she developed polyarticular synovitis in the hands, feet and knees. We...
6.
Brixen K, Illum N, Hansen B, Lund A, Mosekilde L
Ugeskr Laeger
. 2007 Jan;
169(1):30-4.
PMID: 17217883
The molecular background for osteogenesis imperfecta (OI) is mutations in one of the two genes (COL1A1 and COL1A2) encoding collagen I. The disease is characterised by varying degrees of fragile...
7.
Nielsen M, Jorgensen J, Brock Jacobsen B, Hegedus N, Ryg J, Brixen K
Ugeskr Laeger
. 2005 Sep;
167(37):3510-1.
PMID: 16159462
We present three cases of primary hyperparathyroidism (PHPT) in pregnancy. The clinical presentation of PHPT is not altered by pregnancy; however, the disease constitutes a serious risk for the foetus...
8.
Damborg F, Nissen N, Jorgensen H, Abrahamsen B, Brixen K
Ugeskr Laeger
. 2005 Apr;
167(9):1038-41.
PMID: 15804001
No abstract available.
9.
Brixen K, Abrahamsen B, Kassem M, Mosekilde L
Ugeskr Laeger
. 2005 Apr;
167(9):1009-12.
PMID: 15803994
No abstract available.
10.
Tfelt-Hansen J, Brixen K, Mosekilde L, Schwarz P
Ugeskr Laeger
. 2005 Mar;
167(8):924-6.
PMID: 15789851
No abstract available.